Immutep

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.

About IMMP

Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. 

CEO
Marc Voigt
CEOMarc Voigt
Employees
Employees
Headquarters
Sydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded
1987
Founded1987
Employees
Employees

IMMP Key Statistics

Market cap
144.41M
Market cap144.41M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
51.79K
Average volume51.79K
High today
$1.69
High today$1.69
Low today
$1.61
Low today$1.61
Open price
$1.62
Open price$1.62
Volume
18.48K
Volume18.48K
52 Week high
$5.00
52 Week high$5.00
52 Week low
$1.58
52 Week low$1.58

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

IMMP Earnings

Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
per share
Estimated per share
Actual
Expected Jul 30, Pre-Market
ActualExpected Jul 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.